检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《中华检验医学杂志》2014年第1期9-12,共4页Chinese Journal of Laboratory Medicine
基 金:基金项目:国家科技支撑计划课题(2012BA137801)
摘 要:随着生命科学技术的进步,临床检验相关支撑技术的迅速发展,对当今临床生物化学检验提出了更高的要求,在完善的质量管理体系保障下,最大限度地发挥其为临床服务的能力和应用价值。以循证医学为基础,结合我国具体国情及医疗改革的现状,深入评估新项目、新技术的临床价值,加强质量监管措施,为实际应用提供更加客观可靠的依据,科学指导临床决策,对合理配置和利用有限的医疗资源具有深远的意义。同时逐步推进个体化医学发展进程,尝试改变目前较为“被动”的医疗模式,关注疾病的早期预测和预防,以人为本,合理优化治疗方案,加强药物的安全性和有效性,将成为临床生物化学检验的热点问题。With the rapid development of life science and relevant technology of clinical laboratory medicine, it raised higher demands for current clinical biochemistry, which is to maximize the clinical efficacy and application value under the perfect quality management system. Based on the evidence-based medicine, considering the national conditions and the new situation of medical reform, comprehensive assessment the clinical performance of new technologies and new tests, to provide more objective and reliable evidence for practical application and to guide clinical decision making, is of great significance for the rational allocation and utilization of the limited medical resources. At the same time, promoting the development of personalized medicine process gradually, trying to change the "passive" medical model, focusing on the disease prediction, prevention and control, taking people as the foremost, optimizing the treatment plan, and strengthening the safety and efficacy of drugs, will become hot topics of clinical biochemistry.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.248